REG-BARCLAYS PLC Form 8.3 - STAGECOACH GROUP PLC
13/01/2022 13:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220113:nBw3qTB8Ma&default-theme=true
Form 8.3 - STAGECOACH GROUP PLC
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose STAGECOACH GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 12 January 2022
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? NATIONAL EXPRESS GROUP PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 125/228p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 5,954,072 1.08% 698,393 0.13%
(2) Cash-settled derivatives:
669,689 0.12% 5,538,544 1.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 6,623,761 1.20% 6,236,937 1.13%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other
employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
125/228p ordinary Purchase 342 0.9062 GBP
125/228p ordinary Purchase 454 0.9049 GBP
125/228p ordinary Purchase 571 0.9000 GBP
125/228p ordinary Purchase 579 0.9122 GBP
125/228p ordinary Purchase 1,084 0.8975 GBP
125/228p ordinary Purchase 1,995 0.9100 GBP
125/228p ordinary Purchase 2,091 0.8985 GBP
125/228p ordinary Purchase 7,436 0.8992 GBP
125/228p ordinary Purchase 8,217 0.8999 GBP
125/228p ordinary Purchase 13,543 0.9088 GBP
125/228p ordinary Purchase 49,301 0.9072 GBP
125/228p ordinary Purchase 50,614 0.9058 GBP
125/228p ordinary Purchase 63,338 0.9061 GBP
125/228p ordinary Purchase 300,000 0.9075 GBP
125/228p ordinary Sale 4 0.9130 GBP
125/228p ordinary Sale 454 0.9050 GBP
125/228p ordinary Sale 808 0.8922 GBP
125/228p ordinary Sale 942 0.8958 GBP
125/228p ordinary Sale 1,084 0.8975 GBP
125/228p ordinary Sale 1,185 0.8925 GBP
125/228p ordinary Sale 1,244 0.8997 GBP
125/228p ordinary Sale 1,995 0.9100 GBP
125/228p ordinary Sale 2,091 0.8985 GBP
125/228p ordinary Sale 2,219 0.9020 GBP
125/228p ordinary Sale 3,466 0.8917 GBP
125/228p ordinary Sale 7,975 0.8943 GBP
125/228p ordinary Sale 18,190 0.8949 GBP
125/228p ordinary Sale 19,107 0.8973 GBP
125/228p ordinary Sale 23,395 0.9051 GBP
125/228p ordinary Sale 40,027 0.9073 GBP
125/228p ordinary Sale 239,694 0.9103 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
125/228p ordinary SWAP Long 700 0.9101 GBP
125/228p ordinary CFD Long 3,028 0.9049 GBP
125/228p ordinary CFD Long 6,242 0.9017 GBP
125/228p ordinary SWAP Long 12,750 0.9092 GBP
125/228p ordinary CFD Long 17,311 0.9082 GBP
125/228p ordinary SWAP Short 342 0.9062 GBP
125/228p ordinary CFD Short 650 0.8635 GBP
125/228p ordinary SWAP Short 1,067 0.9104 GBP
125/228p ordinary SWAP Short 5,434 0.9079 GBP
125/228p ordinary SWAP Short 8,687 0.8999 GBP
125/228p ordinary SWAP Short 16,209 0.9088 GBP
125/228p ordinary SWAP Short 24,094 0.9077 GBP
125/228p ordinary SWAP Short 33,136 0.9053 GBP
125/228p ordinary CFD Short 37,863 0.9047 GBP
125/228p ordinary SWAP Short 48,234 0.9071 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state
“none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 13 Jan 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be
included, provided contact information has been provided to the Panel’s
Market Surveillance Unit.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=52562614&newsitemid=20220113005546&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=eae3bbb1e10d8914f2828f51061273c4)
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20220113005546/en/
(https://www.businesswire.com/news/home/20220113005546/en/)
BARCLAYS PLC
Copyright Business Wire 2022Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement